Jerry G. Hu, M.D.

Fort Worth Ophthalmologist Jerry G. Hu, M.D.

Fort Worth & Hurst Eye Doctor


Laser Refractive Surgery, Cataract Surgery, Cornea and Anterior Segment Diseases, Glaucoma, Diabetic Exams, Comprehensive Ophthalmology


Hurst & Fort Worth, TX

Throughout his career, Dr. Jerry Hu has been active at the forefront of ophthalmic surgeries, including blade-free wavefront-guided custom LASIK, nano-incision cataract surgery, and no-stitch endothelial cornea transplants. Dr. Hu routinely performs the cutting-edge, sub-2 millimeter, nano-incision cataract surgery.

Dr. Hu is among the select surgeons in the Metroplex area who are fellowship-trained in modern laser refractive surgery, including blade-free IntraLASIK, PRK, as well as wavefront custom treatment. Dr. Hu has pioneered surgical techniques in the sutureless endothelial cornea transplants and the low-recurrence, no-stitch pterygium surgery. In addition, with a strong interest in comprehensive ophthalmology, Dr. Hu has extensive experience in the treatment of glaucoma, diabetic retinopathy, dry eyes, and other ocular diseases.

In 2003, Dr. Jerry Hu joined the Texas Eye Surgery Center, which offers state-of-the-art ophthalmic surgeries in a clean, pleasant, and efficient outpatient setting. The scope of services includes cataractspterygiumglaucomadiabetescornea surgery, YAG, and SLT laser surgeries as well as various other advanced ocular procedures.

Dr. Jerry Hu joined Texas Eye & Laser Center after completing a fellowship in Cornea and Refractive Surgery with the world-renowned Jules Stein Eye Institute at the University of California, Los Angeles. Dr. Jerry Hu graduated with honors from Davidson College, North Carolina, and attended Duke University School of Medicine. Following his internship in California, he returned to Duke and completed his residency in ophthalmology.

Dr. Hu is widely published in various fields of ophthalmic research. His selected memberships include The American Medical Association, American Society of Cataract and Refractive Surgery, The Association for Research in Vision and Ophthalmology, and Texas Medical Association. Dr. Hu also holds multiple memberships in other national and state professional organizations.

Dr. Jerry Hu and his wife, also a physician, have been married for over twenty years and have two sons. The family enjoys traveling, photography, water sports, and skiing. They are dedicated fans of the Cowboys, the Mavericks, the Rangers and the Stars. Dr. Hu also follows the Duke Blue Devils basketball team with zeal.



  • “Best Doctor in Fort Worth”, voted by peers 16 years in a row: 2002-2018


  • Jules Stein Eye Institute, UCLA; Fellowship in Cornea and Refractive Surgery, 2002-2003


  • Duke University Eye Center; Residency, 1999-2002


  • The University of California, San Francisco @ Fresno; Transitional Internship, 1998-1999


  • Duke University School of Medicine, Durham, NC; MD, 1994-1998


  • Davidson College, Davidson, NC: Phi Beta Kappa; BS with Honors, 1990-1993


  • Texas


  • HCA North Hills Hospital, North Richland Hills, Texas
  • Harris Methodist Hospital HEB, Bedford, Texas
  • Texas Eye and Surgery Center, Hurst, Texas


  • American Academy of Ophthalmology
  • American Society of Cataract and Refractive Surgeons
  • Texas Medical Association
  • Tarrant County Medical Association
  • Tarrant County Ophthalmology Association
  • American Society for Prevention of Blindness


  • No-stitch, drop anesthesia, nano-incision cataract surgery
  • Advanced Lifestyle Implants: CrystaLens, ReSTOR, Tecnis Multifocal, Toric implants
  • Blade-free, wavefront-guided custom IntraLASIK
  • Flapless LASEK, PRK
  • Implantable contact lens: EVO ICL
  • Sutureless endothelial cornea transplants
  • Low-recurrence, no-stitch pterygium surgery
  • Full-spectrum corneal surgeries: penetrating keratoplasty (PK), superficial keratectomy (SK), phototherapeutic keratotomy (PTK), etc
  • Glaucoma: medical and laser treatments
  • Diabetes: medical and laser treatments
  • Dry eyes


  • 1998-1999: University of California, San Francisco @ Fresno: Transitional Internship
  • 2002-Present: Fellow Participate in various research projects including the development of surgical techniques of endokeratoplasty, the efficacy of combined penetrating keratoplasty with glaucoma seton implantation, LASIK postoperative studies, etc.
  • 2001-Present: Resident in cooperation with the Alcon Labs, studied the refractive outcome of the new single-piece injectable Acrysof SA60AT IOL in comparison to the conventional 3-piece foldable MA60AC IOL.
  • 2000-2002: Resident Alan Carlson, MD, Director, Cornea Service, Duke University Eye Center. Developed a nomogram to quantify the intraocular pressure change following LASIK for myopia.
  • 1999-2000: Resident Craig Fowler, MD, Duke University Eye Center. Studied the In vitro susceptibilities of ocular isolates in fungal keratitis to posaconazole, a new triazole antifungal agent, and compared it to presently used agents.
  • 1996-1997: Medical Student Fellow, full-time David Epstein, MD, Chairman, Duke University Eye Center. Demonstrated the gene expression of b­tubulin in human trabecular meshwork; evaluated the effect of its altered expression on outflow facility as a potential mode of gene therapy for glaucoma; cloned the then newly recognized TIGR gene.


  • 2020: Visual and Patient-Reported Outcomes of a Diffractive Trifocal Intraocular Lens Compared with Those of a Monofocal Intraocular Lens. American Academy of Ophthalmology Journal. Read the full article here.
  • 1998-1999: University of California, San Francisco @ Fresno: Transitional Internship
  • G. Hu, T. Kim, P. Challa, A. Carlson. Nomogram guided adjustment of measured IOP after LASIK, based only on Refractive Shift. Poster presentation at ASCRS, June 2002. Submitted, American Journal of Ophthalmology, 8/2001.
  • BK. Ambati, G. Hu, et al. Outcomes after Complications of Laser In Situ Keratomileusis (LASIK) requiring Surgical Intervention. Accepted, in the press, AJO. G.
  • Hu, C. Fowler, et al. In vitro susceptibilities of ocular isolates in fungal keratitis to posaconazole, a new triazole antifungal agent. Poster presentation at ARVO, May 2001.
  • G. Hu, P. Challa, S. Fekrat. Ophthalmic Pearl: Aqueous Shunting Implants for the Management of Glaucoma. Eyenet. September 2002.
  • G. Hu, et al. Refractive Outcome of the Injectable SA60AT as Compared to the Foldable MA60AC. To be presented at AAO ¹02 (Alcon booth, Oct 20, 3:30 PM) and ESCRS ¹03.
  • G. Hu, D.L. Epstein, T. Borras, et al. Characterization of the b­tubulin Gene Family in Human Trabecular Meshwork Cells; Modification by Gene Transfer. Poster presentation at ARVO, May 1997.


  • Speaker on multiple products for Bausch & Lomb
  • Site trained and maintains current certificate in Good Clinical Practices (GCPs)
  • Four FDA phase-3 trials in 2012 and 2013
  • Serves as a “rescue site” due to the high volume of clinical pathology, both medical and surgical
  • Large optometric and primary care physician referral network
  • Full time, dedicated research department with 4 Full-Time Employee
  • Impeccable track record of prompt correspondence, meeting deadlines and protocol compliance
  • Fully equipped for clinical research; dedicated clinical space to engage study patients
  • Well acquainted with Central Independent Review Board (IRB) process
(817) 768-6620
(817) 803-6106
Refer a Patient OD Portal Online Bill Pay

HURST Location

1872 Norwood Dr., Suite 200,
Hurst, TX 76054
Map of Our Hurst Location


3405 Locke Ave., Suite 100,
Fort Worth, TX 76107
Map of Our Fort Worth Location